Wordt geladen...
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
OBJECTIVE: To estimate the long-term cost-effectiveness of dapagliflozin versus acarbose as monotherapy in treatment-naïve patients with type 2 diabetes mellitus (T2DM) in China. METHODS: The Cardiff Diabetes Model, an economic model designed to evaluate the cost-effectiveness of comparator therapie...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5091768/ https://ncbi.nlm.nih.gov/pubmed/27806087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0165629 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|